Cita APA

Cardama, G. A., Bucci, P. L., Lemos, J., Llavona, C., Benavente, M. A., Hellmén, E., . . . Alonso, D. F. (2023). In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma. Web

Citación estilo Chicago

Cardama, Georgina Alexandra, et al. In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 As an Antitumor Agent in Canine Mammary Carcinoma. 2023.

Cita MLA

Cardama, Georgina Alexandra, et al. In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 As an Antitumor Agent in Canine Mammary Carcinoma. 2023.